Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China · Delayed Price · Currency is CNY 17.03
+0.03 (0.18%)
At close: Feb 3, 2026
SHE:300181 Revenue
Zhejiang Jolly Pharmaceutical Co.,LTD had revenue of 680.26M CNY in the quarter ending September 30, 2025, with 10.32% growth. This brings the company's revenue in the last twelve months to 2.81B, up 11.51% year-over-year. In the year 2024, Zhejiang Jolly Pharmaceutical Co.,LTD had annual revenue of 2.58B with 32.71% growth.
Revenue (ttm)
2.81B
Revenue Growth
+11.51%
P/S Ratio
4.20
Revenue / Employee
1.32M
Employees
2,125
Market Cap
11.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.58B | 635.44M | 32.71% |
| Dec 31, 2023 | 1.94B | 137.29M | 7.61% |
| Jan 1, 2023 | 1.81B | 347.76M | 23.86% |
| Jan 1, 2022 | 1.46B | 366.52M | 33.60% |
| Dec 31, 2020 | 1.09B | 179.71M | 19.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 53.89B |
| Zhejiang Int'l Group | 33.54B |
| Yifan Pharmaceutical | 5.22B |
| GuangYuYuan Chinese Herbal Medicine | 1.39B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.05B |
| Shanghai InnoStar Bio-tech | 829.92M |
| Chongqing Lummy Pharmaceutical | 771.02M |
| Hangzhou Minsheng Healthcare | 744.06M |